Abstract
The immune system is a sophisticated and complex system that is influenced by various exogenous insults such as surgical stress and endogenous factors like the sympathetic nervous system. It has been demonstrated that sedative agents used in clinical practice alter the balance of pro- and anti-inflammatory cytokines. These effects may be reversible following short exposure to anaesthetic agents and sedative drugs. However, many critically ill patients are sedated for prolonged periods of time, which raises concerns about the risks of immunological interference by sedative agents. When one considers that sepsis accounts for significant morbidity in intensive care, it is imperative that anything modifiable which causes immunosuppression is identified. The systemic inflammatory response syndrome is known to feature an increase in pro-inflammatory mediators, something which could be influenced by sedative agents.
We propose to outline the details surrounding this area, focusing on sedative agents commonly used in the intensive care setting. A more detailed understanding of this area could lead to improved patient outcomes and have far-reaching influence on clinical practice in critical care.
Keywords: Critical care, sedation, immunosuppression, immunomodulation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: The Immunological Side-Effects of Sedative Agents in the Intensive Care Unit
Volume: 9 Issue: 3
Author(s): A. Walsh and K. Ghori
Affiliation:
Keywords: Critical care, sedation, immunosuppression, immunomodulation
Abstract: The immune system is a sophisticated and complex system that is influenced by various exogenous insults such as surgical stress and endogenous factors like the sympathetic nervous system. It has been demonstrated that sedative agents used in clinical practice alter the balance of pro- and anti-inflammatory cytokines. These effects may be reversible following short exposure to anaesthetic agents and sedative drugs. However, many critically ill patients are sedated for prolonged periods of time, which raises concerns about the risks of immunological interference by sedative agents. When one considers that sepsis accounts for significant morbidity in intensive care, it is imperative that anything modifiable which causes immunosuppression is identified. The systemic inflammatory response syndrome is known to feature an increase in pro-inflammatory mediators, something which could be influenced by sedative agents.
We propose to outline the details surrounding this area, focusing on sedative agents commonly used in the intensive care setting. A more detailed understanding of this area could lead to improved patient outcomes and have far-reaching influence on clinical practice in critical care.
Export Options
About this article
Cite this article as:
Walsh A. and Ghori K., The Immunological Side-Effects of Sedative Agents in the Intensive Care Unit, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2010; 9 (3) . https://dx.doi.org/10.2174/1871523011009030229
DOI https://dx.doi.org/10.2174/1871523011009030229 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Physiological Targets Within the Kidney for Antihypertensive Therapy
Drug Design Reviews - Online (Discontinued) Hydrogen Peroxide Produced by Mitochondrial Monoamine Oxidase Catalysis: Biological Implications
Current Pharmaceutical Design Immunological Impact of Whey Protein on Peripheral Blood Mononuclear Cells of Patients with Chronic Liver Disease
Current Nutrition & Food Science Management of Hypertension in Relation to Acute Coronary Syndromes and Revascularisation
Current Pharmaceutical Design 4-Aminocyclopentane-1,3-diols as Platforms for Diversity: Synthesis of Anandamide Analogs
Medicinal Chemistry Ovarian Hyperstimulation Syndrome: The Best Approaches for Preven-tion and Treatment: A Mini-Review
Current Women`s Health Reviews The Role of 5-Hydroxytryptamine in the Pathophysiology of Migraine and its Relevance to the Design of Novel Treatments
Mini-Reviews in Medicinal Chemistry Sulfaphenazole and α-Naphthoflavone Attenuate the Metabolism of the Synthetic Cannabinoids JWH-018 and AM2201 Found in K2/Spice
Drug Metabolism Letters Blood Platelet Reactivity and its Pharmacological Modulation in (People with) Diabetes Mellitus
Current Pharmaceutical Design Geriatric Psychopharmacology in Acute Settings
Current Psychopharmacology Ivabradine: A Current Overview
Current Clinical Pharmacology Pharmacological manipulation of peripheral vascular resistance in special clinical situations after pediatric cardiac surgery
Current Vascular Pharmacology Nitric Oxide and Teratogenesis: An Update
Current Pharmaceutical Design Potential Biomarkers for Depression Associated with Coronary Artery Disease: A Critical Review
Current Molecular Medicine Pharmacological Countermeasures for the Acute Radiation Syndrome
Current Molecular Pharmacology Potential Role of Hydrogen Sulfide in the Pathogenesis of Vascular Dysfunction in Septic Shock
Current Vascular Pharmacology Interventions Against Sarcopenia in Older Persons
Current Pharmaceutical Design Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments
Current Medicinal Chemistry Targeting Sarcomas: Novel Biological Agents and Future Perspectives
Current Drug Targets The Role of Sympathetic Nervous System in the Progression of Chronic Kidney Disease in the Era of Catheter Based Sympathetic Renal Denervation
Current Clinical Pharmacology